Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia.
Anticoagulants
/ therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections
/ complications
Estrogen Replacement Therapy
Female
Heparin, Low-Molecular-Weight
/ therapeutic use
Hormonal Contraception
Hormone Replacement Therapy
Humans
Menopause
Middle Aged
Pandemics
Pneumonia, Viral
/ complications
Risk Factors
SARS-CoV-2
Thromboembolism
/ etiology
COVID-19
Hormone menopause therapy
Venous thromboembolism prophylaxis
Journal
Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
16
04
2020
revised:
25
04
2020
accepted:
29
04
2020
entrez:
6
6
2020
pubmed:
6
6
2020
medline:
10
6
2020
Statut:
ppublish
Résumé
COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antithrombotic strategies, such as the use of low molecular weight heparins (LMWH) at specific prophylactic or treatment doses for each individual case, depending on the risk factors that each woman presents. For such reasons, a panel of experts from various Spanish scientific societies has met to develop usage recommendations for managing menopausal women taking menopausal hormone therapy (MHT) or combined hormonal contraception (CHC) during the COVID-19 pandemic.
Identifiants
pubmed: 32498938
pii: S0378-5122(20)30249-8
doi: 10.1016/j.maturitas.2020.04.019
pmc: PMC7200366
pii:
doi:
Substances chimiques
Anticoagulants
0
Heparin, Low-Molecular-Weight
0
Types de publication
Practice Guideline
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
57-62Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Références
Cochrane Database Syst Rev. 2014 Mar 03;(3):CD010813
pubmed: 24590565
Menopause. 2013 Jul;20(7):754-60
pubmed: 23793166
Blood Rev. 2017 May;31(3):151-157
pubmed: 27998619
J Thromb Haemost. 2020 Jul;18(7):1752-1755
pubmed: 32267998
J Thromb Haemost. 2012 Nov;10(11):2277-86
pubmed: 22963114
Eur J Contracept Reprod Health Care. 2012 Feb;17(1):7-29
pubmed: 22239262
Am J Med. 2020 Jan;133(1):9-11
pubmed: 31247174
J Clin Endocrinol Metab. 2015 Nov;100(11):4012-20
pubmed: 26544651
BMJ. 2019 Jan 9;364:k4810
pubmed: 30626577
N Engl J Med. 2012 Jun 14;366(24):2257-66
pubmed: 22693997
BMJ. 2012 Aug 07;345:e4944
pubmed: 22872710
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
Maturitas. 2014 May;78(1):45-50
pubmed: 24656220
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
West J Med. 1999 Jun;170(6):348-51
pubmed: 18751155